• Username (E-mail)
  • Password
Dow 19,800 -0.1%  EStoxx50 3,281 0.3%  Nikkei 18,788 -0.6%  EUR 1.0731 -0.3% 
Nasdaq 5,553 0.0%  FTSE100 7,172 0.3%  Yen 113.3740 0.7%  Oil 55.5 0.2% 
S&P500 2,265 -0.3%  DAX 11,575 0.3%  GBP 1.2448 -0.7%  Gold 1,212 -0.6% 

Cree share [Symbol: CREE / ISIN: US2254471012]

01/12/2012 10:40:33 AM
01/12/2012 10:40:33 AM UTC-0500

Cree Inc. Hold

The analysts of Kaufman Bros., LP have rated Cree with a Hold rating. The price target was set to 24.00 $. At a current price of the Cree stock of 27.48 $ this means a downside potential of -12.66%.
Summary: Cree Inc. Hold
Company:
Cree Inc.
Analyst:
Kaufman Bros., LP
Price Target:
24.00 $
Current Rating:
Hold
Price*:
23.80 $
Distance to Target Price*:
0.84%
Previous Rating:
Upgrade
Latest Price:
27.48 $
Distance Price Target:
-12.66%
Analyst Name::
-
P/E Ratio*:
-

Analyst Opinions for Cree Inc.

More Analyst Opinions
  • All
  • Buy
  • Hold
  • Sell
12/21/16
Cree Goldman Sachs Group Inc.
08/17/16
Cree Goldman Sachs Group Inc.
10/01/13
Cree Goldman Sachs Group Inc.
12/06/12
Cree D.A. Davidson & Co.
11/30/12
Cree Deutsche Bank Securities

Add or Edit Instrument

Related Stocks

Cree Inc. 27.49 -1.98% Cree Inc.
Latest Analyst Opinions
01/23/17 TLG IMMOBILIEN Norddeutsche Landesbank (Nord/LB)
01/23/17 ABB JP Morgan Chase & Co.
01/23/17 Zurich Insurance Group JP Morgan Chase & Co.
01/23/17 Apple Bernstein Research
01/23/17 Novo Nordisk A-S (B) JP Morgan Chase & Co.
01/23/17 Sky UBS AG
01/23/17 Vodafone Group UBS AG
01/23/17 BT Group UBS AG
01/23/17 RHÖN-KLINIKUM Independent Research GmbH
01/23/17 Credit Suisse Morgan Stanley
01/23/17 Deutsche Bank Morgan Stanley
01/23/17 Intesa Sanpaolo JP Morgan Chase & Co.
01/23/17 HORNBACH Baumarkt Hauck & Aufhäuser Privatbankiers KGaA
01/23/17 RHÖN-KLINIKUM Commerzbank AG
01/23/17 NORMA Group Oddo Seydler Bank AG
01/23/17 Reckitt Benckiser Group Barclays Capital
01/23/17 Deutsche Bank Commerzbank AG
01/23/17 LOréal Barclays Capital
01/23/17 Diageo Barclays Capital
01/23/17 LVMH Moet Hennessy Louis Vuitton Deutsche Bank AG
01/23/17 Renault UBS AG
01/23/17 Continental UBS AG
01/23/17 Daimler UBS AG
01/23/17 adidas Deutsche Bank AG
01/23/17 AstraZeneca Deutsche Bank AG
01/23/17 CompuGroup Medical Baader Bank
01/23/17 Bechtle Baader Bank
01/23/17 Beiersdorf Barclays Capital
01/23/17 Henkel vz Barclays Capital
01/23/17 Unilever Barclays Capital
01/23/17 Unilever Barclays Capital
01/23/17 GlaxoSmithKline Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
01/23/17 Orange Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
01/23/17 BNP Paribas Deutsche Bank AG
01/23/17 Société Générale SA Deutsche Bank AG
01/23/17 zooplus Warburg Research
01/23/17 ASML Baader Bank
01/23/17 Novo Nordisk A-S (B) Kepler Cheuvreux
01/23/17 Vonovia Kepler Cheuvreux
01/23/17 AIXTRON Baader Bank
01/23/17 Anheuser-Busch InBev UBS AG
01/23/17 PUMA Deutsche Bank AG
01/23/17 Glencore UBS AG
01/23/17 BT Group UBS AG
01/23/17 Royal Dutch Shell (A) UBS AG
01/23/17 Eni UBS AG
01/23/17 LOréal UBS AG
01/23/17 PUMA JP Morgan Chase & Co.
01/23/17 Novo Nordisk A-S (B) Goldman Sachs Group Inc.
01/23/17 Hapag-Lloyd Aktiengesellschaft Goldman Sachs Group Inc.